AB
ADAPTIN BIO, INC.
SEC filingBiotechnology · Charlotte, NC
Amount raised$1.9Msold at filing
Total offering$4M$2.1M still open
Investors in the raise19count reported to the SEC
FiledJun 22, 2026first sale Dec 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
L. Arthur HewittExecutive Officer
Patrick GallagherDirector
Michael RobertsExecutive Officer, Director
J. Nick RiehleDirector
Anthony Nick ZookDirector
Timothy Arthur ManessExecutive Officer
Simon Arthur PedderExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.